 |
|
      |
 |
 |
 |
 |
 |
 |
 |
 |
Copyright 2003 |
For
Immediate Release Mesa, Arizona – May 2003 – Paragon Vision Sciences and Carl Zeiss Meditec further enhanced their marketing alliance with the announcement of an exciting new leasing program that covers the Paragon CRT® system and the Humphrey Atlas 995 – the Platinum Advantage Program. Through this program, an eye care practitioner can easily afford to harness the power of both technologies driving substantial increases in practice revenue. The Platinum Advantage Program incorporates the Paragon CRT Diagnostic Dispensing System, the Extended Set and all Paragon CRT practitioner marketing tools and the Humphrey® Atlas™ 995 corneal topographer with a software package, topographer table and printer all in one simple lease program with one low, monthly payment of around $400. “This program makes it incredibly cost effective to add topography and Corneal Refractive Therapy with Paragon CRT to the practice,” commented Joe Sicari, President and CEO of Paragon Vision Sciences. “The practitioner can provide patients the benefits of the latest vision care technology resulting is virtually unparalleled practice revenue growth. For Corneal Refractive Therapy, the Atlas topographer provides the practitioner with the best tool for collecting patient baseline and follow-up data and saves valuable chair time throughout the patient management process. And, the profit from the first Paragon CRT patient each month will not only cover the lease payment but also create incremental profit! It’s a great benefit for the patient and great for the practice.” Joe Donahoe, Executive Vice President for the Americas added, “The Platinum Advantage Program adds even more value to the alliance between Paragon and Carl Zeiss Meditec. Both companies share the common goal of helping the practitioner provide patients with the best technology options in eye care at an affordable adoption cost.” Paragon CRT is the first and only product FDA approved for overnight contact lens corneal reshaping and is routinely manufactured with Paragon HDS 100®, an HDS Technology® material. Paragon CRT is the ideal vision correction option for consumers that desire freedom from the hassles of contact lenses and spectacles during their waking hours, but prefer a non-surgical vision correction alternative. Paragon CRT provides 24-hour vision (the patient can see with the lenses on or off) without the inconvenience of daytime contact lenses and, importantly, allows the eye unencumbered access to oxygen throughout waking hours. Corneal Refractive Therapy with Paragon CRT provides an opportunity for practitioners not involved with refractive surgery to compete in the corneal reshaping market with a non-surgical and reversible option. For practices involved in refractive surgery, Paragon CRT is an ideal complement as it offers an opportunity to appeal to patients who are averse to surgery while providing a “test drive” of the visual freedom that surgery provides. This experience may lead patients to elect surgery in the future. Paragon, in conjunction with their authorized laboratory partners, officially launched Paragon CRT across the United States in August 2002. In 2003, Paragon CRT will become widely available in Canada and eventually worldwide. Paragon Vision Sciences is a privately held, specialty vision products company, located near Phoenix in Mesa, Arizona, which is owned and operated by Joe Sicari, President & CEO and members of his management team. Paragon is the manufacturer of world-renowned oxygen permeable contact lens materials including Paragon HDS®, Paragon HDS® 100, Paragon Thin™, FluoroPerm®, Paraperm® and SportSight® GP. For more information on Paragon CRT and other Paragon products contact an Authorized Paragon Laboratory Partner or the company’s Customer Service Team at 1-800-528-8279 within the United States and Canada or 1-480-892-7602 from other countries. For more information on Paragon CRT, visit www.paragoncrt.com. |